Fosun Medicine exerting force: acquiring "invisible champion" Red Flag pharmacy

Fosun Medicine (600196) has been exerting force to develop international market in the world's second largest infectious disease field.　　December 12, Fosun Pharmaceutical announced that it will be through the transfer of shares by China's anti-TB leading enterprises in Shenyang Red Flag pharmaceutical 70% stake in the arrival of China's largest anti-TB drug production enterprises, the acquisition amount of 320 million yuan. "Anti-TB drugs will be the second business card to enter the global pharmaceutical market after Fosun medicine after artesunate drugs," he said.　　Chen Qiyu, chairman of Fosun Pharmaceutical, said. Malaria, tuberculosis and AIDS are the world's three major infectious diseases, and Fosun Medicine has been certified by WHO in the field of malaria.　　Fosun Medical senior vice president and Pharmaceutical Industry Management committee Chairman Li Xianlin said Fosun Medicine will be in the existing anti-malaria, tuberculosis and other platforms on the basis of promoting China's infectious drugs to the international market.　　Fosun Pharmaceutical and red flag pharmaceutical negotiations for more than 3 years, Red Flag pharmaceutical is a subdivision of the leading enterprises, Fosun Medicine for its value, the latter also fancy Fosun medicine in the international market access and experience.　　Shanghai Fosun Pharmaceutical Group is the only supplier of Chinese pharmaceutical enterprises through WHO-GMP certification and PQ certification so far. Shenyang Red Flag pharmaceutical company originally belongs to East Medicine group, in 1998 under the leadership of the incumbent chairman Kang Shusen transformed into private enterprises, is currently listed in China's three independent research and development of a new type of anti-TB drug production enterprises and quality standards of the drafting unit, and has independent intellectual property rights.　　Red Flag Pharmaceutical has become the World Health Organization recommended to the global focus on the production of anti-TB drugs, the Ministry of China "TB control project" Drug designated production enterprises, China's largest anti-TB drug development and production base. "Anti-TB drugs are basically procured by government, and red flags can be won in almost all government projects."　　Muhong, director of the China National Defense and Tuberculosis Association, told reporters that red Flag pharmaceutical is the largest supplier of anti-TB drugs in China, but some certification procedures are needed to move to the international market. Kang Shusen said, "Fosun Pharmaceutical successfully through the WHO's PQ certification, hope that the cooperation after Fosun can help accelerate the promotion of red flag pharmaceutical anti-TB line, second-line drugs through who GMP and PQ certification, as soon as possible into the global market." ”